Oncotarget

Research Papers:

chr19_34670, a newly identified miRNA, represses rapid tumor growth of cystic vestibular schwannomas by targeting transforming growth factor α and inhibiting MAPK pathway

Zirong Huo, Shuang Yan, Tao Yang, Zhentao Wang, Qi Huang, Zhaoyan Wang, Hongsai Chen, Penghui Chen, Huan Jia, Zhihua Zhang _ and Hao Wu

PDF  |  HTML  |  Supplementary Files  |  How to cite

DOI pending

Metrics: PDF 324 views  |   HTML 507 views  |   ?  


Abstract

Zirong Huo1,2,3,*, Shuang Yan1,2,3,*, Tao Yang1,2,3, Zhentao Wang1,2,3, Qi Huang2,3, Zhaoyan Wang1,2,3, Hongsai Chen1,2,3, Penghui Chen1,2,3, Huan Jia1,2,3, Zhihua Zhang1,2,3 and Hao Wu1,2,3

1Department of Otolaryngology-Head & Neck Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

2Ear Institute, Shanghai Jiaotong University School of Medicine, Shanghai, China

3Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases, Shanghai, China

*These authors have contributed equally to this work

Correspondence to:

Zhihua Zhang, email: [email protected]

Hao Wu, email: [email protected]

Keywords: miRNA; cystic vestibular schwannoma; proliferation; tumor growth; pathogenesis

Received: March 16, 2017    Accepted: July 29, 2017    Published: January 02, 2018

ABSTRACT

Purpose: Cystic vestibular schwannoma (CVS) is an aggressive form of vestibular schwannoma (VS) with rapid growth and poor outcomes. The molecular basis of CVS remains unclear. In this study, we aimed to investigate whether microRNAs (miRNAs) contribute to the development of CVS.

Methods: We identified miRNAs that were differentially expressed between CVS and solid VS (SVS) tissues using high-throughput sequencing and quantitative real-time PCR analysis. Gene targets of the identified miRNA were predicted by bioinformatics tools and validated by luciferase reporter analysis. The effects of the miRNA and its target genes on the proliferation of primary VS cells were examined using CCK-8, flow cytometry, colony formation assay, and western-blot.

Results: We identified a novel miRNA, chr19_34670, downregulated in CVS compared to SVS. chr19_34670 directly targeted the 3’ untranslated region of transforming growth factor α (TGFα) mRNA and suppressed its expression. TGFα overexpression motivated VS cell proliferation, while this effect could be attenuated by chr19_34670. We also found that chr19_34670 inhibited the function of key proteins in the MAPK pathway by suppressing phosphorylation of ERK and MEK.

Conclusions: chr19_34670 suppresses the aggressive proliferation observed in CVS by inhibiting TGFα expression and phosphorylated proteins in the MAPK pathway.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20712